Gilead Sciences GILD
NASDAQ GILD
$170.35 +0.62 (+0.37%)
As of: Nov 12, 2026 · 11:30 AM EST

Gilead Sciences (GILD) Non-Current Deferred Revenue (2009 - 2013)

Updated

Analysis

Gilead Sciences (GILD) Non-Current Deferred Revenue (2009 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 21.98 Mn
Sep 30, 2013 25.40 Mn
Jun 30, 2013 28.77 Mn
Mar 31, 2013 32.20 Mn
Dec 31, 2012 20.53 Mn
Sep 30, 2012 20.84 Mn
Jun 30, 2012 23.66 Mn
Mar 31, 2012 26.51 Mn
Dec 31, 2011 31.87 Mn
Sep 30, 2011 34.70 Mn
Jun 30, 2011 27.71 Mn
Mar 31, 2011 30.28 Mn
Dec 31, 2010 32.84 Mn
Sep 30, 2010 39.45 Mn
Jun 30, 2010 39.53 Mn
Mar 31, 2010 41.49 Mn
Dec 31, 2009 43.03 Mn
Sep 30, 2009 44.57 Mn
Jun 30, 2009 53.42 Mn
Mar 31, 2009 51.29 Mn
API Access

Gilead Sciences Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=GILD&period=max&api_key=YOUR_API_KEY